MannKind Corp (MNKD)
4.32
+0.14
(+3.35%)
USD |
NASDAQ |
Apr 26, 10:12
MannKind Cash from Investing (TTM): -1.988M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -1.988M |
September 30, 2023 | 20.92M |
June 30, 2023 | 59.81M |
March 31, 2023 | 58.17M |
December 31, 2022 | 4.874M |
September 30, 2022 | -22.72M |
June 30, 2022 | -45.07M |
March 31, 2022 | -159.62M |
December 31, 2021 | -151.54M |
September 30, 2021 | -143.44M |
June 30, 2021 | -148.43M |
March 31, 2021 | -36.05M |
December 31, 2020 | 15.22M |
September 30, 2020 | 19.49M |
June 30, 2020 | 23.26M |
March 31, 2020 | 22.04M |
December 31, 2019 | -22.84M |
September 30, 2019 | -22.88M |
June 30, 2019 | -26.64M |
March 31, 2019 | -25.27M |
December 31, 2018 | -0.234M |
September 30, 2018 | 0.01M |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.024M |
December 31, 2017 | 16.68M |
Date | Value |
---|---|
September 30, 2017 | 16.68M |
June 30, 2017 | 16.68M |
March 31, 2017 | 16.65M |
December 31, 2016 | -1.127M |
September 30, 2016 | -1.439M |
June 30, 2016 | -2.593M |
March 31, 2016 | -7.127M |
December 31, 2015 | -10.20M |
September 30, 2015 | -24.10M |
June 30, 2015 | -23.17M |
March 31, 2015 | -26.89M |
December 31, 2014 | -24.10M |
September 30, 2014 | -16.05M |
June 30, 2014 | -16.06M |
March 31, 2014 | -7.937M |
December 31, 2013 | -7.987M |
September 30, 2013 | -1.882M |
June 30, 2013 | -1.776M |
March 31, 2013 | -1.728M |
December 31, 2012 | -0.56M |
September 30, 2012 | -0.624M |
June 30, 2012 | -1.094M |
March 31, 2012 | -5.063M |
December 31, 2011 | -2.937M |
September 30, 2011 | -10.92M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-159.62M
Minimum
Mar 2022
59.81M
Maximum
Jun 2023
-29.34M
Average
-22.72M
Median
Sep 2022
Cash from Investing (TTM) Benchmarks
Cassava Sciences Inc | -0.414M |
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |